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Eight new ﬂuorescent ligands (L1-L8) derived from the fused imidazo[4,5-f]-1,10-phenanthroline core,
have been synthesised utilising a one-pot methodology. The ligands include two points of structural
variety, allowing multiply-substituted aryl groups (including hydroxy and methoxy moieties) to be
attached to the ligand core. The ligands L1-L8 are ﬂuorescent (lem ¼ 399e426 nm) and react with
pentacarbonylbromorhenium to give coordination complexes of the form fac-[ReBr(CO)3(N^N)] (where
N^N ¼ L1-L8). The complexes were characterised using a variety of spectroscopic and analytical tech-
niques, including single crystal X-ray diffraction studies on two examples. The rhenium complexes were
all found to be luminescent, revealing classical 3MLCT emission at 579e587 nm in aerated solution with
corresponding lifetimes in the range 149e166 ns.
© 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).1. Introduction
Lophine (2,4,5-triphenylimidazole [1]) based chromophores
(Scheme 1) have been known for >50 years [2] and primarily
investigated for their ﬂuorescence and chemiluminescence prop-
erties [3]. Syntheses have been developed [4] and the emission
characteristics can be tuned through the imidazole substituents [5].
These systems have shown great application in analytical disci-
plines [6]. The versatility and ease of functionalisation of the
lophine core has allowed a huge variety of new systems to be
developed including those that have application in coordination
chemistry. The closely related fused unit imidazo[4,5-f]-1,10-
phenanthroline (Scheme 1) has become a popular ligand motif in
the last few years, and can be easily functionalised for a variety of
potential applications. For example, metallomesogens based on
imidazo[4,5-f]-1,10-phenanthroline have been described that
incorporate metal ions such as Pt(II), Ln(III) and uranyl [7].Fallis), popesj@cardiff.ac.uk
r B.V. This is an open access articlOne of the most common metal ions to be used in conjunction
with imidazo[4,5-f]-1,10-phenanthroline type ligands is Ru(II).
Such complexes have been studied for their excited state properties
[8] and biological application [9], particularly with respect to DNA
binding, which is promoted by the planar imidazo[4,5-f]-1,10-
phenanthroline ligand. Ru(II) complexes of 4-(1H-imidazo[4,5-f]-
1,10-phenanthrolin-2-yl)benzene-1,2-diol (a ligand closely related
to those in this paper) have also been reported showing pH
dependent luminescence properties [10]. Imidazo[4,5-f]-1,10-
phenanthroline derived ligands have also been combined with
metal ions such as Ir(III), [11] Pt(II), [12] and Cu(I) [13] complexes,
and have also been used in the development of a chemosensor for
Co(II) ions [14]. Ir(III) complexes with a coumarin chromophore
conjugated to the imidazo[4,5-f]-1,10-phenanthroline core have
been developed for the efﬁcient photogeneration of singlet oxygen
[15]. This ligand class has also been utilised in the design of metal
complexes for cell imaging studies. Examples of Ir(III), which show
good two-photon excitation properties [16], and aggregation-
induced phosphorescence [17,18] have been successfully explored
in targeted imaging. Related Ru(II) complexes have demonstrated
mitochondrial targeting behaviour through cell imaging studies
and have been postulated as anticancer agents [19]. The potentiale under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Scheme 1. Molecular structures of 2,4,5-triphenylimidazole (left) and 2-
phenylimidazo[4,5-f]-1,10-phenanthroline (right).
Scheme 2. Route to the new ligands and complexes: (a) conc. H2SO4, conc. HNO3,
NaBr; (b) S1-CHO, S2-NH2, AcOH; (c) ReBr(CO)5, toluene, D.
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development of coordination polymers (including for the f-block)
[20] and also in the design of complex architectures with inter-
esting magnetic properties [21].
In the context of Re(I), only a handful of reports exist on the
coordination chemistry of imidazo[4,5-f]-1,10-phenanthroline type
ligands, including within heterobimetallic assemblies [22]. In our
previous studies we have shown that the imidazo[4,5-f]-1,10-
phenanthroline ligand is ideally suited to Re(I) allowing the for-
mation of [ReBr(CO)3(N^N)] type complexes; the substitution of
different groups at the ligand core can allow subtle tuning of the
3MLCT wavelengths when incorporated into Re(I) complexes [23].
Interest in luminescent d6 Re(I) has ﬂourished over the last few
decades. In particular, [ReX(CO)3(N^N)] complexes provide huge
opportunity for the design of complexes for different optoelectronic
applications since the luminescent properties of fac-[ReX(CO)3(-
diimine)] type complexes are often ascribed to metal-to-ligand
charge transfer (MLCT) excited states [24,25]. Such complexes
have found application in the design of chemosensors
[26,27,28,29,30,31,32] and cell imaging agents [33].
In this paper we present the synthesis of a new series of chro-
mophoric ligands based upon the fused imidazo[4,5-f]-1,10-
phenanthroline core that are functionalised with different
substituted aryl groups. We report the synthesis and spectroscopic
characterisation of eight new fac-[Re(Br(CO)3(N^N)] complexes,
including the X-ray structures of two examples. The variation in
ligand structure is discussed in the context of the photophysical
properties of the complexes.2. Results and discussion
2.1. Synthesis and characterisation
The ligands (L1-L8) were synthesised according to an adaption
of previously reported approaches (Scheme 2), allowing a range of
aryl amine (S2-NH2) and aldehyde (S1-CHO) reagents to be utilised
in the procedure. The functionalised imidazo[4,5-f]-1,10-
phenanthroline ligands possessed good solubility in a range of
organic solvents (imparted by the different substituted aryl groups,
S1 and S2) and were characterised using a range of standard
spectroscopic and analytical techniques, conﬁrming the proposed
formulations in each case. The relevant details and data are pre-
sented in the experimental section. The coordination chemistry of
the ligands (L1-L8) was explored with Re(I), wherein heating
stoichiometric equivalents of ligand and ReBr(CO)5 in toluene for
24 h produced the desired complexes as yellow coloured solids of
the general formulation fac-[ReBr(CO)3(N^N)] (where N^N¼ L1-L8).Solid-state IR spectroscopic studies were conducted on the
complexes to reveal either two or three bands, the two lower fre-
quency absorption often overlapping, suggesting the local sym-
metry can be approximated to Cs or C3v symmetry as expected for
the facially capped coordination geometry. There is very little
variation in the CO stretching frequencies suggesting that the
donating ability of the diimine ligand is comparable across the
series of complexes. High resolution electrospray mass spectrom-
etry (positive mode) showed that the neutral complexes fragment
in a predictable manner. The axial bromide ligand is substituted
with MeCN, resulting in an overall cationic species
[Re(CO)3(MeCN)(N^N)]þwith an isotopic distribution consistent for
rhenium (and loss of Br). 1H and 13C{1H} NMR spectra were ob-
tained for each complex and were consistent with the presence of
the coordinated ligands in all cases. Typically, in the 1H NMR the
aromatic resonances of the phenanthroline fragment are shifted
downﬁeld upon coordination to rhenium suggesting a binding
mode to the diimine domain rather than via the catechol-like ter-
minating groups in L1 and L2. For the ligands incorporating the
methoxy substituents, the -OCH3 resonances appear around
3.8 ppm and were relatively insensitive to coordination to Re(I).2.2. X-ray structures of the complexes
Single crystal X-ray diffraction studies were undertaken on two
complexes, fac-[ReBr(CO)3(L4)] and fac-[ReBr(CO)3(L6)]. Suitable
Table 1
Data collection parameters for the X-ray crystal structures.
Empirical formula C35H30BrN4O6Re C34H28BrN4O5Re
fac-[ReBr(CO)3(L6)] fac-[ReBr(CO)3(L4)]
Formula weight 868.74 838.71
Temperature 100(2) K 100(2) K
Wavelength 0.71075 Å 0.71075 Å
Crystal system Monoclinic Triclinic
Space group P21/c P-1
Unit cell dimensions a ¼ 11.686(5) Å, a ¼ 90
b ¼ 12.634(5) Å, b ¼ 93.380(7)
c ¼ 24.0993(10) Å, g ¼ 90
a ¼ 11.1587(8) Å, a ¼ 111.784(8)
b ¼ 13.0479(10) Å, b ¼ 110.740(8)
c ¼ 13.1431(10) Å, g ¼ 97.685
Volume 3552(2) Å3 1582.4(2) Å3
Z 4 2
Density (calculated) 1.625 Mg/m3 1.760 Mg/m3
Absorption coefﬁcient 4.594 mm¡1 5.150 mm¡1
F(000) 1704 820
Crystal Block; yellow Column; yellow
Crystal size 0.05  0.02  0.02 mm3 0.27  0.06  0.06 mm3
q range for data collection 2.98e25.03 2.58e27.55
Index ranges 15  h  15, 16  k  16,
29  l  31
14  h  13, 16  k  16,
13  l  17
Reﬂections collected 61116 19957
Independent reﬂections 6269 [Rint ¼ 0.1111] 7218 [Rint ¼ 0.0468]
Completeness to qmax 99.8% 98.9%
Absorption correction Semiempirical from equivalents Semiempirical from equivalents
Max. and min. transmission 0.914 and 0.803 0.747 and 0.337
Reﬁnement method Full-matrix least-squares on F2 Full-matrix least-squares on F2
Data/restraints/parameters 6269/53/461 7218/0/411
Goodness-of-ﬁt on F2 1.314 1.010
Final R indices [F2 > 2s(F2)] R1 ¼ 0.0742, wR2 ¼ 0.1620 R1 ¼ 0.0333, wR2 ¼ 0.0797
R indices (all data) R1 ¼ 0.0825, wR2 ¼ 0.1660 R1 ¼ 0.0412, wR2 ¼ 0.0828
Largest diff. peak and hole 1.419 and 0.813e Å¡3 2.087 and 2.051 e Å¡3
Fig. 1. Ortep3 plot of complex fac-[ReBr(CO)3(L6)]. Ellipsoids are drawn at 50% prob-
ability. In the crystal structure tert-butyl goup is disordered and modelled over two
positions with 53/47 ratio. For clarity only one component is shown. Selected data -
bond lengths (Å): C33Re1, 1.955(15); C34Re1, 1.954(13); C35Re1, 1.930(13);
N3Re1, 2.181(8); N4Re1, 2.179(9); Br1Re1, 2.6430(13). Bond angles():
O6C33Re1, 173.8(10); O5C34Re1, 178.9(10); O4C35Re1, 176.0(11);
C19N3Re1, 125.6(6); C18N3Re1, 115.9(6); C16N4Re1, 126.5(7); C17N4Re1,
115.8(6); C35Re1C33, 86.7(5); C35Re1C34, 90.1(4); C33Re1C34, 88.8(5);
C35Re1N4, 173.3(4); C33Re1N4, 94.1(4); C34Re1N4, 96.6(4); C35Re1N3,
97.7(4); C33Re1N3, 96.9(4); C34Re1N3, 170.6(3); N4Re1N3, 75.6(3);
C35Re1Br1, 95.3(4); C33Re1Br1, 178.0(3); C34Re1Br1, 91.3(3); N4Re1Br1,
83.9(2); N3Re1Br1, 82.8(2).crystals were obtained by the slow diffusion of hexane into a
toluene solution of the complex solution over a period of 72 h. The
parameters associated with the data collection for both complexes
are shown in Table 1, with selected bond length and angle data in
the corresponding ﬁgure captions (Figs. 1 and 2).
Both structures reveal the expected coordination environment
for the d6 Re(I) in each case with L4/L6 chelating trans to two
carbonyl ligands, with the third CO ligand and bromide donors
occupying axial positions. Bond lengths and angles are typical for a
{ReBr(CO)3} complex of a chelating diimine [34]. For fac-
[ReBr(CO)3(L6)] the imidazo[4,5-f]-1,10-phenanthroline core of the
ligand framework is essentially co-planar with the ‘Re(CO)2’ frag-
ment of the complex, whilst the trimethoxy-phenyl group deviates
from co-planarity with the heterocyclic core of the ligand with a
torsion angle of 25.0; the p-tert-butylphenyl group is almost
orthogonal to the ligand core with a torsion angle of 81.8 (the tert-
butyl group is also disordered). An increased torsion angle (away
from planarity) is observed (65.8) for the apical substituent “R” of
fac-[ReBr(CO)3(L4)] compared to fac-[ReBr(CO)3(L6)]. This is most
likely due to the ortho-positioning of the methoxy substituent on
the apical phenyl in fac-[ReBr(CO)3(L4)], which bears only a H atom
for fac-[ReBr(CO)3(L6)]. The added steric clashing that would be
involved with the sidearm R0 group results in signiﬁcant rotation of
the apical group. An increased torsion angle away from planarity
such as this reduces the effective conjugation of the ligand
fragment.
2.3. UV-vis. Absorption and visible luminescence studies
The UV-vis and luminescence data were collected for L1-L8. In
general, the absorption spectra (obtained on either aerated DMSO
or chloroform solutions at room temperature) revealed a number of
strong bands dominating the UV region below 350 nm, which are
assigned to variousp/p* transitions. It is also possible that weaker
n/p* bands may contribute to a lower energy portion of the
spectra (350e425 nm). The precise positioning of these bands was
subtly dependent upon the nature of the aryl substitution in S1 and
Fig. 2. Ortep3 plot of complex fac-[ReBr(CO)3(L4)]. Ellipsoids are drawn at 80% prob-
ability and hydrogen atoms have been omitted for clarity. Selected data - bond lengths
(Å): C32Re1, 1.931(4); C34Re1, 1.926(4); C33Re1, 1.908(4); Br1Re1, 2.6332(5);
N1Re1, 2.171(3); N2Re1, 2.177(3). Bond angles(): O1C32Re1, 178.7(3);
O3C34Re1, 177.2(4); O2C33Re1, 177.7(4); C1N1Re1, 125.7(3); C5N1Re1,
115.8(2); C12N2Re1, 125.2(3); C9N2Re1, 116.0(2); C33Re1C34, 90.55(17);
C33Re1C32, 89.01(17); C34Re1C32, 88.91(17); C33Re1N1, 171.05(13);
C34Re1N1, 95.09(14); C32Re1N1, 98.01(15); C33Re1N2, 97.57(15);
C34Re1N2, 93.49(14); C32Re1N2, 172.96(15); N1Re1N2, 75.20(12);
C33Re1Br1, 90.24(12); C34Re1Br1, 177.25(11); C32Re1Br1, 93.74(12);
N1Re1Br1, 83.81(8); N2Re1Br1, 83.79(8).
R.O. Bonello et al. / Journal of Organometallic Chemistry 841 (2017) 39e4742S2 (Scheme 2). Corresponding time resolved luminescence data
showed that each of the ligands was ﬂuorescent (lifetimes 3.3e4.3
ns) with emission wavelengths in the range 399e423 nm (Fig. 3).Fig. 3. Comparison of the normalised emission spectra of selected ligands
(lex ¼ 265 nm; 105 M CHCl3).The slightly broadened and unstructured emission peaks suggest
that the origin of the emission may be a mixture of 1p-p* and n-p*
excited states. The very subtle variation in values can be attributed
to the different substitution patterns of S1 and S2. The data suggests
that the change in hydroxyl/methoxy substitution pattern at S1
induces more pronounced changes in emission wavelength for the
free ligands than the variations at S2. L1 possessed the most
bathochromically shifted ﬂuorescence wavelength.
For the complexes, two main absorption characteristics were
observed. Firstly, the high energy ligand-centred p/p* transitions
are expected for the extended p-framework at 260e330 nm, and
secondly the presence of a weaker band that tails into the visible
region 1MLCT absorption (Re(d)/p*) with the longest wavelengths
observed at >400 nm as broadened shoulders. This data is consis-
tent with that obtained for related Re(I) complexes that incorporate
the imidazo[4,5-f]-1,10-phenanthroline chromophore [23]. Across
the series of complexes there was a subtle shift in the 1MLCT ab-
sorption wavelengths (408e426 nm) for the isolated complexes
with orthomethoxy-substitution of the S1 group leading to slightly
higher 1MLCT energies. In comparison, the 1MLCT absorption
(Re(5d)/p*) for [ReCl(CO)3(phen)] has been reported at 383 nm,
which is a higher energy absorption compared to the value of the
complexes described herein, reﬂecting the increased conjugation
across the imidazole[4,5-f]-1,10-phenanthroline core.
In the luminescence studies, following irradiation of the 1MLCT
band ~410 nm, the Re(I) complexes all showed a broad unstruc-
tured emission peak ca. 580 nm in aerated chloroform (Table 2).
This observed emission is therefore distinct from the ﬂuorescence
noted for the corresponding free ligands, and was associated with a
relatively large Stokes' shift (~6500 cm1). Fig. 4 shows the exci-
tation and emission spectra for fac-[ReBr(CO)3(L4)] (together with
other selected emission spectra) where it is clear from the emission
proﬁle that there is no residual ﬂuorescence from the imidazole
[4,5-f]-1,10-phenanthroline ligand. The excitation spectrum shows
aweak feature around 500 nm, whichmay be due to a direct 3MLCT
excitation. Corresponding emission lifetimes for these complexes
lie in the range 149e166 ns, which are characteristic of neutral Re(I)
based lumophores of this type, and again suggest that ﬂuorescence
from the ligand is quenched [23]. Taken together, and in compari-
son to related examples in the literature, the emission properties
from this series of complexes can therefore be characterised as
3MLCT in nature. Despite the variation noted in the 1MLCT ab-
sorptions, the emission data suggests that the 3MLCT energy is
relatively insensitive to the variation of the substituents attached to
the imidazole[4,5-f]-1,10-phenanthroline ligand.3. Conclusion
The one-pot synthesis described herein has allowed a variety of
ﬂuorescent imidazole[4,5-f]-1,10-phenanthroline based ligands to
be isolated, incorporating a variety of hydroxy- and methoxy sub-
stituents. The ligands react conveniently with ReBr(CO)5 to give
complexes of the general formulation fac-[ReBr(CO)3(N^N)] (where
N^N ¼ L1-L8). Two examples were characterised using X-ray crys-
tallography and conﬁrm the proposed formulations of the com-
plexes. Each of the rhenium complexes possessed a 3MLCT emitting
state giving visible luminescence in ﬂuid medium at room tem-
perature, and it was shown that this could be subtly tuned via the
electronic character of the substituents at the ligand. The func-
tionality of the ligands, in particular the hydroxyl-substituted
species lends themselves to further reactivity towards multime-
tallic supramolecular architectures (i.e. the complexes themselves
can be used as synthons).
Table 2
IR, UV-vis. and luminescence spectroscopic data for the complexes.
Complex y(CO)/cm1a 1MLCT, labs/nmb 3MLCT, lem/nmc,d 3MLCT, t/nsd,e
fac-[ReBr(CO)3(L1)] 2023, 1912, 1884 418 580 (423) 166 (4.1)
fac-[ReBr(CO)3(L2)] 2022, 1896 br 418 587 (417) 156 (4.0)
fac-[ReBr(CO)3(L3)] 2020, 1892 br 414 578 (400) 168 (3.3)
fac-[ReBr(CO)3(L4)] 2020, 1891 br 418 580 (399) 163 (3.3)
fac-[ReBr(CO)3(L5)] 2020, 1869 br 425 579 (421) 163 (4.3)
fac-[ReBr(CO)3(L6)] 2020, 1894 br 426 580 (419) 158 (4.2)
fac-[ReBr(CO)3(L7)] 2020, 1891 br 417 580 (411) 149 (3.6)
fac-[ReBr(CO)3(L8)] 2020, 1893 br 408 584 (416) 149 (3.6)
a Solid state.
b CHCl3 solution 1  105 M.
c lex ¼ 365 nm or 410 nm, CHCl3 solution 1  105 M.
d Values in parentheses are for the corresponding free ligand (L1-L8).
e lex ¼ 372 nm, CHCl3 solution 1  105 M.
Fig. 4. Left: Example of excitation (lem ¼ 580 nm) and emission (lex ¼ 355 nm) spectra for selected complexes (105 M CHCl3). Right: example of a lifetime decay (with ﬁt) for
[ReBr(CO)3(L5)].
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All reactions were performed with the use of vacuum line and
Schlenk techniques. Reagents were commercial grade and were
used without further puriﬁcation. [ReBr(CO)5] was prepared ac-
cording to the literature procedure [35]. 1,10-phenanthroline-5,6-
dione prepared as previously reported [36]. 1H and 13C-{1H} NMR
spectra were run on NMR-FT Bruker 400 or 250 spectrometers and
recorded in CDCl3. 1H and 13C-{1H} NMR chemical shifts (d) were
determined relative to internal TMS and are given in ppm. Low-
resolution mass spectra were obtained by the staff at Cardiff Uni-
versity. High-resolution mass spectra were carried out by at the
EPSRC National Mass Spectrometry Service at Swansea University.
UV-Vis studies were performed on a Jasco V-570 spectrophotom-
eter as MeCN solutions (105 M). Photophysical data were obtained
on a JobinYvon-Horiba Fluorolog spectrometer ﬁtted with a JY TBX
picosecond photodetection module as MeCN solutions. Emission
spectra were uncorrected and excitation spectra were instrument
corrected. The pulsed source was a Nano-LED conﬁgured for
372 nm output operating at 1 MHz. Luminescence lifetime proﬁles
were obtained using the JobinYvon-Horiba FluoroHub single
photon counting module and the data ﬁts yielded the lifetime
values using the provided DAS6 deconvolution software.4.1. Data collection and processing
X-ray diffraction datasets were measured on a Rigaku AFC12
diffractometer equipped with enhanced sensitivity (HG)
Saturn724 þ CCD detector mounted at the window of an FR-
E þ SuperBright rotating anode generator (Mo Ka, l ¼ 0.71075 Å)
with VHF Varimax optics (70 mm focus) [37] using Crystal Clear
software [38] for data collection and reduction.
4.2. Structure analysis and reﬁnement
The structures were solved by direct methods using SHELXS-97
[39] and reﬁned on Fo2 by full-matrix least-squares reﬁnements
using SHELXL [40] within the OLEX2 suite [41]. All non-hydrogen
atoms were reﬁned with anisotropic displacement parameters,
and all hydrogen atoms were added at calculated positions and
reﬁned using a riding model with isotropic displacement parame-
ters based on the equivalent isotropic displacement parameter
(Ueq) of the parent atom. In the crystal structure of fac-
[ReBr(CO)3(L6)] -tertbutyl group is disordered and modelled over
two positions with 53/47 ratio. Only one component is shown.
SIMU, DELU and RIGU restraints were used to model appropriately
atomic displacement parameters.
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Diffraction data for fac-[ReBr(CO)3(L4)] and fac-[ReBr(CO)3(L6)]
were collected on a Nonius KappaCCD using graphite-
monochromated Mo-Ka radiation (l ¼ 0.71073 Å) at 150 K. Soft-
ware package Apex 2 (v2.1) was used for the data integration,
scaling and absorption correction.
4.4. Structure analysis and reﬁnement
The structure was solved by direct methods using SHELXS-97
and was completed by iterative cycles of DF-syntheses and full-
matrix least squares reﬁnement. All non-H atoms were reﬁned
anisotropically and difference Fourier syntheses were employed in
positioning idealised hydrogen atoms and were allowed to ride on
their parent C-atoms. All reﬁnements were against F2 and used
SHELX-97.
4.5. Synthesis
4.5.1. Synthesis of L1
This material was prepared by combining 3,4-dihydroxy benz-
aldehyde (0.198 g, 1.43 mmol), 1,10-phenanthroline-5,6-dione
(0.300 g, 1.43 mmol), 3,5-dimethylaniline (0.18 ml, 1.43 mmol)
and ammonium acetate (1.10 g, 14.3 mmol) in acetic acid (10 ml).
The reaction mixture was stirrer vigorously under reﬂux for 4 h,
subsequently allowed to cool to room temperature and poured over
crushed ice (200 g). The mixture was neutralised with aqueous
ammonia. Bleach (several drops, sodium hypochlorite solution)
was added to remove strongly coloured impurities and the result-
ing solutionwas extracted with dichloromethane (4  50 ml). After
drying over MgSO4 the solvent was removed and the crude product
was recrystallised from a small volume of warm chloroform with
the subsequent addition of hexane to yield product (L1) as a pale
brown powder (0.346 g, 0.80 mmol, 56%). 1H NMR (400 MHz, d6-
DMSO): d 9.06 (1H, d, J ¼ 3.0 Hz), 8.97 (1H, d, J ¼ 7.7 Hz), 8.92
(1H, d, J ¼ 3.1 Hz), 7.85 (1H, dd, J ¼ 7.8, 4.3 Hz), 7.48 (1H, dd, J ¼ 8.4,
4.2 Hz), 7.37 (1H, s), 7.32 (3H, m), 7.22 (1H, d, J ¼ 1.9 Hz), 6.81 (1H,
dd, J ¼ 8.3, 1.9 Hz), 6.66 (1H, d, J¼ 8.3 Hz), 2.38 (6H, s) ppm. 13C{1H}
NMR (101 MHz, d6-DMSO): d 152.1, 148.4, 147.3, 146.9, 145.0, 143.7,
143.6, 143.5, 140.1, 137.8, 134.9, 134.8, 131.8, 127.3, 126.2, 123.7,
123.4, 122.6, 120.9, 120.5, 119.5, 116.8, 115.3, 20.8 ppm. HRMS
(ES)(%): found m/z ¼ 433.1658 [M þ H]þ; {C27H20N4O2}þ requires
433.1659. IR (KBr plates): 3155 (bs), 1610 (m), 1601 (m), 1567 (m),
1510 (m), 1484 (s), 1425 (m), 1392 (w), 1343 (m), 1287 (s), 1240 (s),
1115 (w), 1081 (w), 1023 (w), 888 (m), 830 (m), 808 (m), 740
(s) cm1. UV-vis lmax (ε/M1 cm 1) (DMSO): 262 (sh) (54 200), 280
(58 500), 304 (sh) (46 300) nm.
4.5.2. Synthesis of L2
This material was prepared by a similar method to L1 using 3,4-
dihydroxy benzaldehyde (0.198 g,1.43mmol),1,10-phenanthroline-
5,6-dione (0.300 g, 1.43 mmol), 4- terbutylaniline (0.23 ml,
1.43 mmol) and ammonium acetate (1.10 g, 14.3 mmol). The crude
product was recrystallised using chloroform and hexane to give
product (L2) as a brown/green powder (0.270 g, 0.80 mmol). 1H
NMR (400 MHz, MeOD): d 9.01 (2H, m), 8.92e8.84 (1H, m),
7.84e7.67 (3H, m), 7.55e7.30 (4H, m), 7.07 (1H, d, J ¼ 2.1 Hz), 6.82
(1H, dd, J¼ 8.2, 2.1 Hz), 6.69 (1H, d, J¼ 8.2 Hz), 1.45 (9H, s) ppm. 13C
{1H} NMR (101 MHz, MeOD): d 155.12, 154.60, 149.25, 148.42,
148.30, 146.37, 144.68, 144.38, 136.15, 135.75, 131.51, 129.55, 129.24,
128.45, 127.40, 126.51, 124.81, 123.56, 122.75, 121.66, 120.96, 120.78,
117.93, 115.92, 35.94, 31.74 ppm. HRMS (ES)(%): found m/
z ¼ 461.1976 [M þ H]þ; {C29H25N4O2}þ requires 461.1972. IR (KBr
plates): 3058 (bw), 2961 (m), 1598 (m), 1576 (w), 1563 (w), 1511 (s),1464 (w), 1438 (m), 1392 (w), 1364 (w), 1267 (s), 1110(w), 1033 (w),
993 (w), 910 (w), 808 (m), 740 (s) cm1. UV-vis lmax (ε/M1 cm 1)
(CHCl3): 276 (31 800), 316(sh) (15 500), 423 (3100) nm.
4.5.3. Synthesis of L3
This material was prepared by a similar method to L1 using 2,3-
dimethoxy benzaldehyde (0.237 g, 1.43 mmol), 1,10-
phenanthroline-5,6-dione (0.300 g, 1.43 mmol), 3,5-
dimethylaniline (0.18 ml, 1.43 mmol) and ammonium acetate
(1.10 g, 14.3 mmol). The crude product was recrystallised using
chloroform and hexane to give product (L3) as an off-white powder
(0.390 g, 0.85 mmol). 1H NMR (400 MHz, CDCl3): d 9.17 (1H, dd,
J ¼ 4.4, 1.8 Hz), 9.10 (1H, dd, J ¼ 8.1, 1.8 Hz), 9.05 (1H, dd, J ¼ 4.3,
1.6 Hz), 7.72 (1H, dd, J¼ 8.1, 4.4 Hz), 7.51 (1H, dd, J¼ 8.4,1.6 Hz), 7.32
(1H, dd, J ¼ 8.4, 4.3 Hz), 7.10 (1H, s), 7.07e6.90 (5H, m), 3.85 (3H, s),
3.80 (3H, s), 2.32 (6H, s). 13C{1H} NMR (101 MHz, CDCl3): d 153.0,
149.2, 148.7, 148.3,140.0,137.3, 136.1, 131.9, 130.9,128.8,126.7,126.1,
125.6, 124.5, 124.1, 124.0, 123.9, 122.6, 120.3, 118.0, 114.6, 62.0, 56.4,
21.7 ppm. HRMS (ES)(%): found m/z ¼ 461.1968 [M þ H]þ;
{C29H25N4O2}þ requires 461.1972. IR (KBr plates): 2937 (s), 1594
(m), 1562 (m), 1521 (w), 1502 (m), 1475 (s), 1420 (w), 1393 (w), 1377
(w), 1341 (w), 1263 (s), 1233 (w), 1168 (w), 1083 (s), 1045 (m), 999
(m), 856 (w), 824 (m), 809 (m), 742 (s) cm1. UV-vis lmax (ε/M1 cm
1) (CHCl3): 256 (55 600), 276 (sh) (42 500), 312 (14 000) nm.
4.5.4. Synthesis of L4
This material was prepared by a similar method to L1 using 2,3-
dimethoxy benzaldehyde (0.237 g, 1.43 mmol), 1,10-
phenanthroline-5,6-dione (0.300 g, 1.43 mmol), 4-tertbutylaniline
(0.23 ml, 1.43 mmol) and ammonium acetate (1.10 g, 14.3 mmol).
The crude product was recrystallised using chloroform and hexane
to give product (L4) as an off-white powder (0.350 g, 0.72 mmol).
1H NMR (400 MHz, CDCl3): d 9.24e9.20 (1H, m), 9.16 (1H, d,
J¼ 6.8 Hz), 9.08 (1H, dd, J¼ 4.3, 1.5 Hz), 7.77 (1H, dd, J¼ 8.1, 4.4 Hz),
7.51e7.42 (3H, m), 7.39e7.29 (3H, m), 6.99 (3H, m), 3.83 (3H, s), 3.77
(3H, s), 1.35 (9H, s) ppm. 13C{1H} NMR (101 MHz, CDCl3): d 153.1,
152.6, 150.8, 148.8, 148.3, 148.0, 144.8, 144.3, 135.9, 134.4, 130.6,
128.3, 127.7, 126.7, 126.5, 125.4, 124.2, 123.9, 123.7, 123.5, 122.2,
120.0, 114.3, 61.6, 56.0, 35.0, 31.4 ppm. HRMS (ES)(%): found m/
z ¼ 489.2280 [M þ H]þ; {C31H29N4O2}þ requires 489.2285. IR (KBr
plates): 2958 (m), 1599 (m), 1578 (m), 1560 (m), 1511 (s), 1465 (s),
1389 (w), 1339 (w), 1304 (w), 1263 (s), 1238 (w), 1131 (w), 1083 (s),
1071 (s), 1052 (s), 1004 (s), 989 (s), 872 (w), 847 (w), 818 (m), 806
(m), 797 (m), 785 (m) cm1. UV-vis lmax (ε/M1 cm 1) (CHCl3): 270
(97 600), 352 (sh) 2500 nm.
4.5.5. Synthesis of L5
This material was prepared by a similar method to L1 using
3,4,5-trimethoxy benzaldehyde (0.281 g, 1.43 mmol), 1,10-
phenanthroline-5,6-dione (0.300 g, 1.43 mmol), 3,5-
dimethylaniline (0.18 ml, 1.43 mmol) and ammonium actetate
(1.10 g, 14.3 mmol). The crude product was recrystallised using
chloroform and hexane to give product (L5) as a brown powder
(0.600 g, 1.22 mmol). 1H NMR (400 MHz, CDCl3): d 9.19 (1H, dd,
J ¼ 4.4, 1.8 Hz), 9.15 (1H, dd, J ¼ 8.1, 1.8 Hz), 9.06 (1H, dd, J ¼ 4.3,
1.6 Hz), 7.76 (1H, dd, J ¼ 8.1, 4.4 Hz), 7.51 (1H, dd, J ¼ 8.4, 1.6 Hz),
7.36e7.30 (2H, m), 7.20 (2H, s), 6.93 (2H, s), 3.86 (3H, s), 3.72 (6H, s),
2.43 (6H, s) ppm. 13C{1H} NMR (101 MHz, CDCl3): d 152.97, 151.60,
148.90, 147.97, 144.65, 144.13, 140.92, 139.01, 138.27, 135.76, 131.98,
130.92, 128.37, 127.10, 126.33, 125.03, 124.01, 123.64, 122.43, 120.02,
106.50, 61.05, 55.95, 21.41 ppm. HRMS (ES)(%): found m/
z ¼ 491.2076 [MþH]þ; {C30H27N4O3}þ requires 491.2078. IR (KBr
plates): 2935 (w), 1661 (w), 1588 (m), 1561 (w), 1523 (w), 1480 (m),
1418 (m), 1346 (w), 1247 (w), 1236 (w), 1126 (s), 1025 (w), 1000 (w),
804 (w), 738 (s) cm1. UV-vis lmax (ε/M1 cm 1) (CHCl3): 278
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4.5.6. Synthesis of L6
This material was prepared by a similar method to L1 using
3,4,5-trimethoxy benzaldehyde (0.281 g, 1.43 mmol), 1,10-
phenanthroline-5,6-dione (0.300 g, 1.43 mmol), 4-tertbutylaniline
(0.23 ml, 1.43 mmol) and ammonium acetate (1.10 g, 14.3 mmol).
The crude product was recrystallised using chloroform and hexane
to give product (L6) as a brown powder (0.400 g, 0.77 mmol). 1H
NMR (400 MHz, CDCl3): d 9.16 (2H, m), 9.04 (1H, dd, J ¼ 4.3, 1.6 Hz),
7.75 (1H, dd, J ¼ 8.1, 4.4 Hz), 7.70e7.65 (2H, m), 7.54e7.46 (3H, m),
7.34e7.28 (2H, m), 6.84 (2H, s), 3.84 (3H, s), 3.67 (6H, s), 1.44 (9H, s).
13C{1H} NMR (101 MHz, CDCl3): d 153.9, 152.9, 151.6, 148.9, 147.9,
144.7, 144.2, 138.9, 135.8, 135.6, 130.7, 128.3, 128.1, 127.6, 126.9,
125.0, 123.9, 123.5, 122.3, 119.9, 106.4, 61.0, 55.9, 35.2, 31.4 ppm.
HRMS (ES)(%): found m/z ¼ 519.2386 [M þ H]þ; {C32H31N4O3}þ
requires 519.2391. IR (KBr plates): 2965 (w), 1584 (m), 1559 (m),
1511 (s), 1473 (s), 1404 (m), 1344 (w), 1294 (w), 1247 (m), 1234 (m),
1187 (w), 1128 (s), 1069 (w), 1003 (m), 853 (m), 805 (m), 741
(s) cm1. UV-vis lmax (ε/M1 cm 1) (CHCl3): 281 (46 100), 314 (sh)
(25 300), 361 (sh) (1600) nm.
4.5.7. Synthesis of L7
This material was prepared by a similar method to L1 using,
2,3,4-trimethoxy benzaldehyde (0.280 g, 1.43 mmol), 1,10-
phenanthroline-5,6-dione (0.300 g, 1.43 mmol), 3,5-
dimethylaniline (0.18 ml, 1.43 mmol) and ammonium acetate
(1.10 g, 14.3 mmol). The crude product was recrystallised using
chloroform and hexane to give product (L7) as a brown powder
(0.290 g, 0.59 mmol). 1H NMR (400 MHz, CDCl3): d 9.18 (1H, dd,
J ¼ 4.4, 1.7 Hz), 9.11 (1H, dd, J ¼ 8.1, 1.7 Hz), 9.07 (1H, dd, J ¼ 4.3,
1.6 Hz), 7.74 (1H, dd, J¼ 8.1, 4.4 Hz), 7.56 (1H, dd, J¼ 8.4,1.6 Hz), 7.34
(1H, dd, J ¼ 8.4, 4.3 Hz), 7.09 (4H, m), 6.64 (1H, d, J ¼ 8.6 Hz), 3.86
(3H, s), 3.77 (6H, d, J ¼ 1.5 Hz), 2.33 (6H, s) ppm. 13C{1H} NMR
(101 MHz, CDCl3): d 186.6, 175.4, 155.3, 152.7, 151.0, 148.8, 147.9,
144.3, 143.8, 141.9, 139.5, 137.0, 135.5, 131.4, 131.0, 128.6, 126.6,
126.2, 125.8, 124.1, 123.6, 122.4, 120.0, 117.0, 106.8, 61.4, 60.9, 56.1,
21.3 ppm. HRMS (ES)(%): found m/z ¼ 491.2069 [M þ H]þ;
{C30H27N4O3}þ requires 491.2078. IR (KBr plates): 2935 (w), 2556
(w), 1750 (w), 1714 (s), 1612 (s), 1599 (s), 1563 (m), 1531 (w), 1510
(m), 1472 (s), 1429 (w), 1383 (w), 1341 (w), 1293 (s), 1233 (s), 1099
(s), 1061 (m), 1037 (s), 921 (m), 890 (m), 827 (s), 804 (s), 738
(s) cm1. UV-vis lmax (ε/M1 cm 1) (CHCl3): 258 (53 900), 275(sh)
(45 900), 314(sh) (9900), 362 (1600) nm.
4.5.8. Synthesis of L8
This material was prepared by a similar method to L1 using
2,3,4-trimethoxy benzaldehyde (0.280 g, 1.43 mmol), 1,10-
phenanthroline-5,6-dione (0.300 g, 1.43 mmol), 4-tertbutylaniline
(0.23 ml, 1.43 mmol) and ammonium acetate (1.10 g, 14.3 mmol).
The crude product was recrystallised using chloroform and hexane
to give product (L8) as a light brown powder (0.250 g, 0.48 mmol).
1H NMR (400 MHz, CDCl3): d 9.17 (1H, dd, J ¼ 4.4, 1.8 Hz), 9.11 (1H,
dd, J ¼ 8.1, 1.8 Hz), 9.05 (1H, dd, J ¼ 4.3, 1.6 Hz), 7.73 (1H, dd, J ¼ 8.1,
4.4 Hz), 7.58 (1H, dd, J ¼ 8.4, 1.6 Hz), 7.49e7.45 (2H, m), 7.35e7.29
(3H, m), 7.17 (1H, d, J ¼ 8.5 Hz), 6.67 (1H, d, J ¼ 8.6 Hz), 3.87 (3H, s),
3.68 (6H, d, J¼ 5.5 Hz), 1.36 (9H, s) ppm. 13C NMR (101MHz, CDCl3):
d 155.3, 153.0, 152.5, 151.3, 148.9, 148.0, 144.8, 144.3, 141.8, 135.9,
134.6, 130.7, 128.5, 127.9, 126.8, 126.4, 126.4, 124.2, 123.6, 122.2,
120.0, 117.4, 107.0, 61.4, 61.0, 56.2, 35.0, 31.4 ppm. HRMS (EI)(%):
found m/z ¼ 519.2380; {C32H31N4O3} requires 519.2380. IR (KBr
plates): 2960 (s), 2017 (w), 1915 (w), 1601 (m), 1561 (w), 1512 (m),
1464 (s), 1410 (m), 1340 (w), 1293 (s), 1222 (w), 1095 (s), 1070 (m),
1037 (m), 1013 (m), 985 (w), 807 (w), 748 (s), cm1. UV-vis lmax
(ε/M1 cm 1) (CHCl3): 270 (77 900), 427 (sh) (2000) nm.4.5.9. Synthesis of fac-[ReBr(CO)3(L1)]
Into a round bottom ﬂask was L1 (0.053 g, 0.123 mmol), pen-
tacarbonylbromorhenium (0.05 g, 0.123 mmol) and toluene (30 ml)
and the reactants were left at reﬂux for 3 h under a nitrogen at-
mosphere. The solvent was removed in vacuo to yield orange oil.
The residue was dissolved in CHCl3 (2 ml) to which was added
hexane to yield a precipitate that upon ﬁltration afforded
[ReBr(CO)3(L1)] as a yellow/green powder (0.065 g). 1H NMR
(400 MHz, d6-DMSO): d 9.52 (1H, bs), 9.43 (1H, d, J ¼ 5.1 Hz), 9.34
(1H, d, J ¼ 8.2 Hz), 9.29 (2H, m), 8.18 (1H, dd, J ¼ 8.2, 5.2 Hz), 7.84
(1H, dd, J¼ 8.6, 5.1 Hz), 7.56 (1H, d, J¼ 8.6 Hz), 7.43 (2H, s), 7.36 (1H,
s), 7.26 (1H, d, J ¼ 1.9 Hz), 6.87 (1H, dd, J ¼ 8.3, 1.8 Hz), 6.69 (1H, d,
J ¼ 8.3 Hz), 2.40 (6H, d, J ¼ 2.7 Hz). 13C{1H} NMR (101 MHz, d6-
DMSO): d 154.0, 152.1, 151.1, 147.5, 145.2, 143.9, 143.9, 140.5, 140.4,
136.9, 135.5, 132.9, 132.3, 130.2, 127.0, 126.1, 126.0, 125.9, 125.3,
121.6, 120.8, 120.1, 117.9, 116.8, 115.4, 20.9 ppm. HRMS (ES)(%):
foundm/z ¼ 803.0035 [Mþ Na]þ; {C30H20BrN4NaO5185Re}þ requires
803.0039. IR (KBr plates): 2921 (w), 2023 (s), 1913 (s), 1884 (s), 1616
(w), 1593 (w), 1516 (w), 1447 (w), 1273 (w), 819 (w) cm1. UV-vis
lmax (ε/M1 cm 1) (CHCl3): 275 (45 800), 308(sh) (30 000),
359(sh) (10 000), 418 (5700) nm.
4.5.10. Synthesis of fac-[ReBr(CO)3(L2)]
The title compound was prepared in a similar manner to
[ReBr(CO)3(L1)] but using L2 (0.057 g, 0.123 mmol) and penta-
carbonylbromorhenium (0.05 g, 0.123 mmol) to give the product
[ReBr(CO)3(L2)] as a yellow/green solid (0.080 g). 1H NMR
(400 MHz, CDCl3): d 9.34 (1H, s), 9.28e9.10 (2H, m), 7.81 (2H, m),
7.64 (2H, d, J¼ 8.7 Hz), 7.49 (3H, m), 7.13 (1H, bs), 6.50 (1H, bs), 6.21
(1H, bs), 1.48 (6H, s) ppm. HRMS (ES)(%): found m/z ¼ 807.0366
[M þ H]þ; {C32H23BrN4O5185Re} requires 807.0387. IR (KBr plates):
2022 (s),1896 (bs),1599 (m),1511 (m),1450 (m),1399 (w),1362 (w),
1269 (w), 1108 (w), 808 (m), 724 (m) cm1. UV-vis lmax (ε/M1 cm
1) (CHCl3): 276 (38 600), 357(sh) (8500), 418 (6200) nm.
4.5.11. Synthesis of fac-[ReBr(CO)3(L3)]
The title compound was prepared in a similar manner to
[ReBr(CO)3(L1)] but using L3 (0.057 g, 0.123 mmol) and penta-
carbonylbromorhenium (0.05 g, 0.123 mmol) to give the product
[ReBr(CO)3(L3)] as a green solid (0.085 g). 1H NMR (400 MHz,
CDCl3): d 9.38 (1H, d, J¼ 4.0 Hz), 9.34 (1H, d, J¼ 8.2 Hz), 9.29 (1H, d,
J¼ 5.0 Hz), 7.92 (1H, dd, J¼ 8.2, 5.2 Hz), 7.67 (1H, d, J¼ 8.5 Hz), 7.54
(1H, m), 7.19 (1H, s), 7.09e6.90 (5H, m), 3.85 (3H, s), 3.81 (3H, s),
2.35 (6H, s) ppm. 13C{1H} NMR (101 MHz, CDCl3): d 197.3, 197.3,
189.3,153.1,153.0,152.0,151.3,148.6,145.8,145.4,140.8,140.7,136.1,
133.3, 132.8, 130.8, 127.1, 126.5, 125.8, 125.6, 125.3, 124.4, 123.4,
122.4, 115.3, 62.0, 56.4, 21.7. HRMS (ES)(%): found m/z ¼ 809.0546
[M þ H]þ; {C32H25O5N4Br185Re} requires 809.5032. IR (KBr plates):
2020 (s),1892 (bs),1709 (w),1594 (w),1478 (m),1399 (w),1345 (w),
1267 (m), 1234 (w), 1078 (w), 1059 (w), 999 (w), 808 (w), 725 (w)
cm1. UV-vis lmax (ε/M1 cm 1) (CHCl3): 261 (77 700), 287 (sh)
(46,800), 414 (6500) nm.
4.5.12. Synthesis of fac-[ReBr(CO)3(L4)]
The title compound was prepared in a similar manner to
[ReBr(CO)3(L1)] but using L4 (0.060 g, 0.123 mmol) and penta-
carbonylbromorhenium (0.05 g, 0.123 mmol) to give the product
[ReBr(CO)3(L4)] as a yellow solid (0.085 g). 1H NMR (400 MHz,
CDCl3): d 9.39 (1H, dd, J ¼ 5.1, 1.2 Hz), 9.32 (1H, dd, J ¼ 8.3, 1.1 Hz),
9.27 (1H, dd, J ¼ 5.1, 0.9 Hz), 7.93 (1H, dd, J ¼ 8.2, 5.2 Hz), 7.65 (1H,
dd, J ¼ 8.6, 0.9 Hz), 7.55e7.48 (3H, m), 7.36 (2H, m), 7.11e7.03 (1H,
m), 7.03e6.93 (2H, m), 3.85 (3H, s), 3.76 (3H, s), 1.37 (9H, s) ppm. 13C
{1H} NMR (101 MHz, CDCl3): d 197.6, 197.6, 189.7, 154.6, 153.7, 153.3,
152.1, 151.3, 148.7, 146.0, 145.5, 137.1, 134.0, 133.4, 130.9, 128.2, 127.9,
127.8, 127.7, 127.5, 127.1, 126.6,125.5,125.0,124.8, 123.7, 122.8, 115.3,
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[M þ H]þ; {C34H29BrN4O5185Re}þ requires 837.0845. IR (KBr plates):
2020 (s), 1891 (bs),1709 (w),1600 (w),1512 (w),1478 (m),1459 (m),
1266 (m), 1085 (w), 1061 (w), 993 (w), 808 (w), 725 (w) cm1. UV-
vis lmax (ε/M1 cm 1) (CHCl3): 262 (115 800), 418 (1800) sh nm.
4.5.13. Synthesis of fac-[ReBr(CO)3(L5)]
The title compound was prepared in a similar manner to
[ReBr(CO)3(L1)] but using L5 (0.060 g, 0.123 mmol) and penta-
carbonylbromorhenium (0.05 g, 0.123 mmol) to give product
[ReBr(CO)3(L5)] as a green powder (0.080 g). 1H NMR (400 MHz,
CDCl3): d 9.41e9.33 (2H, m), 9.27 (1H, dd, J ¼ 5.1, 1.2 Hz), 7.95 (1H,
dd, J ¼ 8.2, 5.2 Hz), 7.66 (1H, dd, J ¼ 8.6, 1.2 Hz), 7.53 (1H dd, J ¼ 8.6,
5.1 Hz), 7.38 (1H, s), 7.20 (1H, bs), 6.96 (2H, s), 3.88 (3H, s), 3.73 (6H,
s), 2.47 (3H, s), 2.45 (3H, s) ppm. 13C{1H} NMR (101 MHz, CDCl3)
d 153.6, 153.2, 153.2, 151.7, 150.8, 145.4, 145.1, 141.8, 141.5, 139.70,
137.4, 136.5, 133.1, 132.7, 130.4, 127.5, 126.3, 126.1, 125.8, 125.1, 124.1,
122.2, 106.6, 63.66, 61.1, 56.0, 21.5, ppm. HRMS (ES)(%): found m/
z ¼ 863.0467 [M þ Na]þ; {C33H26BrN4O6187ReNa}þ requires
863.0469. IR (KBr plates): 2020 (s), 1869 (bs), 1589 (m), 1479 (m),
1235 (w), 1126 (m), 999 (w), 808 (w), 725 (w) cm1. UV-vis lmax
(ε/M1 cm 1) (CHCl3): 278 (30 200), 347(sh) (8600), 425 (3700) sh
nm.
4.5.14. Synthesis of fac-[ReBr(CO)3(L6)]
The title compound was prepared in a similar manner to
[ReBr(CO)3(L1)] but using L6 (0.063 g, 0.123 mmol) and penta-
carbonylbromorhenium (0.05 g, 0.123 mmol) to give product
[ReBr(CO)3(L6)] as a yellow powder (0.086 g). 1H NMR (400 MHz,
CDCl3): d 9.41e9.34 (2H, m), 9.26 (1H, dd, J ¼ 5.1, 1.2 Hz), 7.95 (1H,
dd, J ¼ 8.2, 5.2 Hz), 7.76 (2H, d, J ¼ 8.6 Hz), 7.69 (1H, dd, J ¼ 8.6,
1.2 Hz), 7.54e7.48 (3H, m), 6.86 (2H, s), 3.87 (3H, s), 3.68 (6H, s),1.47
(9H, s) ppm. 13C{1H} NMR (101 MHz, CDCl3): d 197.2, 197.1, 189.2,
155.3, 153.9, 153.4, 152.0, 151.0, 145.7, 145.3, 140.0, 134.8, 133.2,
130.3, 128.5, 128.4, 128.2, 127.6, 126.3, 126.3, 125.2, 123.9, 122.3,
106.9, 61.3, 56.3, 35.6, 31.7 ppm. HRMS (ES)(%): found m/
z¼ 869.0962 [Mþ H]þ; {C35H31BrN4O6187Re}þ requires 869.0963. IR
(KBr plates): 2960 (m), 2020 (s), 1894 (s), 1585 (w), 1512 (w), 1477
(m), 1414 (m), 1383 (w), 1345 (w), 1301 (w), 1235 (m), 1127 (s), 1056
(w), 846 (w), 807 (w), 725 (m) cm1. UV-vis lmax (ε/M1 cm 1)
(CHCl3): 278 (46 700), 341 (sh) (14 700), 426 (6000) sh nm.
4.5.15. Synthesis of [ReBr(CO)3(L7)]
The title compound was prepared in a similar manner to
[ReBr(CO)3(L1)] using L7 (0.060 g, 0.123 mmol) and pentacarbo-
nylbromorhenium (0.05 g, 0.123 mmol) to give product
[ReBr(CO)3(L7)] as a yellow solid (0.075 g). 1H NMR (400 MHz,
CDCl3): d 9.38 (1H, s), 9.34e9.25 (2H, m), 7.97e7.89 (1H, m), 7.72
(1H, d, J ¼ 7.9 Hz), 7.57e7.50 (1H, m), 7.18 (1H, s), 7.11e7.02 (3H, m),
6.67 (1H, d, J ¼ 8.4 Hz), 3.88 (3H, s), 3.78 (6H, s), 2.35 (6H, s) ppm.
13C NMR (101 MHz, CDCl3): d 155.8, 153.3, 152.6, 151.5, 150.8, 145.4,
145.0, 141.9, 140.3, 140.1, 136.5, 136.3, 132.9, 132.1, 130.5, 126.8,
126.6, 126.4, 126.1, 125.7, 125.3, 124.9, 122.2, 116.5, 107.1, 61.6, 61.0,
56.2, 21.4, 21.4 ppm. HRMS (EI)(%): found m/z ¼ 841.0642;
{C33H27BrN4O6Re} requires 841.0653. IR (KBr plates): 2935 (w),
2020 (s), 1891 (s), 1599 (m), 1508 (w), 1474 (m), 1427(w), 1412 (w),
1293 (m), 1233 (w), 1215 (w), 1096 (m), 1055 (w), 1011 (w), 807 (w),
725 (w) cm1. UV-vis lmax (ε/M1 cm 1) (CHCl3): 239 (55 800), 261
(85 700), 295 (sh) (38 400), 417 (6300) sh nm.
4.5.16. Synthesis of [ReBr(CO)3(L8)]
The title compound was prepared in a similar manner to
[ReBr(CO)3(L1)] but using L8 (0.064 g, 0.123 mmol) and penta-
carbonylbromorhenium (0.05 g, 0.123 mmol) to give product
[ReBr(CO)3(L8)] as a yellow solid (0.065 g). 1H NMR (400 MHz,CDCl3): d 9.33e9.30 (1H, m), 9.25 (1H, dd, J ¼ 8.2, 1.2 Hz), 9.21 (1H,
d, J ¼ 4.1 Hz), 7.86 (1H, dd, J ¼ 8.2, 5.1 Hz), 7.73e7.69 (1H, m),
7.49e7.42 (3H, m), 7.30e7.22 (2H, m), 7.09 (1H, d, J ¼ 8.6 Hz), 6.63
(1H, d, J ¼ 8.6 Hz), 3.81 (3H, s), 3.64e3.60 (6H, m), 1.31 (9H, s) ppm.
13C NMR (101 MHz, CDCl3) d 155.8, 153.9, 153.6, 152.3, 151.6, 150.8,
145.4, 145.0, 141.9, 136.6, 133.6, 132.9, 130.4, 127.8, 127.6, 127.0,
126.8, 126.6, 126.5, 126.1, 124.9, 122.2, 116.5, 107.2, 61.4, 61.0, 56.2,
35.2, 31.4 ppm. LRMS (ESþ): found m/z 830.12; {C37H33N5O6Re}þ
requires 830.20. IR (KBr plates): 2962 (w), 2020 (s), 1893 (bs), 1709
(m), 1600 (m), 1512 (m), 1463 (m), 1412 (w), 1342 (w), 1292 (m),
1221 (m), 1096 (m), 1081 (m), 808 (m) cm1. UV-vis lmax (ε/M1 cm
1) (CHCl3): 274 (260 000), 408 (3800) sh nm.
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